Device used in treatment.The device was discarded and will not be returned for evaluation.There was no specific performance related failure reported by the user.No further investigation is required.The device history records were reviewed to confirm that the device passed all applicable in-process and final inspections before shipping to the customer.Based on the investigation, a capa is not required as findings did not identify a design, labeling or manufacturing non-conformity.The event will be re-evaluated if additional information becomes available.No further follow-up is required.
|
The patient endured a retroperitoneal bleed caused by the introducer.As treatment, heparin was reduced and the bleed was contained.After bleeding was contained, heparin was resumed.On (b)(6) 2019, the patient exhibited an irregular heart rhythm, coded and expired.It was reported there was no allegation that the oscor device caused or contributed to the death.However it was reported the oscor device was alleged to have caused the bleed, the customer reported the death was not reported as related to the bleed.No specific product problem was reported.The device was discarded.Additional information has been requested.
|